These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 4050651)
1. Propafenone therapy for ventricular tachycardia in the setting of congestive heart failure. Brodsky MA; Allen BJ; Abate D; Henry WL Am Heart J; 1985 Oct; 110(4):794-9. PubMed ID: 4050651 [TBL] [Abstract][Full Text] [Related]
2. Propafenone: noninvasive evaluation of efficacy. Podrid PJ; Cytryn R; Lown B Am J Cardiol; 1984 Nov; 54(9):53D-59D. PubMed ID: 6496369 [TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic and electrophysiologic effects of oral propafenone. Prystowsky EN; Heger JJ; Chilson DA; Miles WM; Hubbard J; Zipes DP Am J Cardiol; 1984 Nov; 54(9):26D-28D. PubMed ID: 6496366 [TBL] [Abstract][Full Text] [Related]
4. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. Coumel P; Leclercq JF; Assayag P Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770 [TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia. Connolly SJ; Kates RE; Lebsack CS; Echt DS; Mason JW; Winkle RA Am J Cardiol; 1983 Dec; 52(10):1208-13. PubMed ID: 6359849 [TBL] [Abstract][Full Text] [Related]
6. Propafenone treatment of recurrent ventricular tachycardia: comparison of continuous electrocardiographic recording and electrophysiologic study in predicting drug efficacy. Heger JJ; Hubbard J; Zipes DP; Miles WM; Prystowsky EN Am J Cardiol; 1984 Nov; 54(9):40D-44D. PubMed ID: 6496368 [TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia. Chilson DA; Heger JJ; Zipes DP; Browne KF; Prystowsky EN J Am Coll Cardiol; 1985 Jun; 5(6):1407-13. PubMed ID: 3889099 [TBL] [Abstract][Full Text] [Related]
8. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation. Doherty JU; Waxman HL; Kienzle MG; Cassidy DM; Marchlinski FE; Buxton AE; Josephson ME J Am Coll Cardiol; 1984 Aug; 4(2):378-81. PubMed ID: 6736479 [TBL] [Abstract][Full Text] [Related]
9. Propafenone: a new agent for ventricular arrhythmia. Podrid PJ; Lown B J Am Coll Cardiol; 1984 Jul; 4(1):117-25. PubMed ID: 6376591 [TBL] [Abstract][Full Text] [Related]
10. Aggravation of electrically provoked ventricular tachycardia during treatment with propafenone. Stavens CS; McGovern B; Garan H; Ruskin JN Am Heart J; 1985 Jul; 110(1 Pt 1):24-9. PubMed ID: 4013986 [TBL] [Abstract][Full Text] [Related]
11. [The treatment of arrhythmias in infants and children using propafenone]. Dressler F; Grävinghoff L; Grütte E; Jüngst BK; Liersch R; Nomayo H; Puls I; Rautenburg HW; Schmaltz A; Schumacher G Monatsschr Kinderheilkd; 1985 Mar; 133(3):154-7. PubMed ID: 4010670 [TBL] [Abstract][Full Text] [Related]
12. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases]. Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161 [TBL] [Abstract][Full Text] [Related]
13. Propafenone for the treatment of refractory complex ventricular ectopic activity. Hammill SC; Sorenson PB; Wood DL; Sugrue DD; Osborn MJ; Gersh BJ; Holmes DR Mayo Clin Proc; 1986 Feb; 61(2):98-103. PubMed ID: 3945115 [TBL] [Abstract][Full Text] [Related]
14. Acute and long-term efficacy of oral propafenone in patients with ventricular tachyarrhythmias. Budde T; Borggrefe M; Podczeck A; Martinez-Rubio A; Breithardt G J Cardiovasc Pharmacol; 1991 Aug; 18(2):254-60. PubMed ID: 1717787 [TBL] [Abstract][Full Text] [Related]